Country for PR: United Kingdom
Contributor: PR Newswire Europe
Wednesday, March 09 2022 - 04:06
AsiaNet
First Surgeries Completed with Patient-Specific 3D Printed Implants Produced at the Limacorporate Promade Point of Care Center at Hospital for Special Surgery
UDINE, Italy, March 9, 2022 /PRNewswire-AsiaNet/ --

LimaCorporate S.p.A., leading global orthopedics manufacturer, and Hospital for 
Special Surgery (HSS), consistently ranked number one in orthopedics globally 
by Newsweek and nationally by U.S. News & World Report in the U.S., today 
announced a new milestone in their collaboration.  The first patient-specific 
solutions designed and produced at the ProMade Point of Care Center for Complex 
Orthopedic Solutions at HSS (ProMade PoC) were successfully used in two complex 
joint reconstruction surgeries. 

One case was a hip procedure performed by hip and knee surgeon Robert L. Buly 
[https://www.hss.edu/physicians_buly-robert.asp], MD, at HSS in New York City, 
while the other was a shoulder procedure performed by orthopedic surgeon 
Patrick Connor, MD, at the OrthoCarolina Center in Charlotte N.C. 

Luigi Ferrari, LimaCorporate CEO, stated, "The successful completion of these 
first two ProMade surgeries produced at the ProMade PoC Center is a source of 
pride for LimaCorporate. It demonstrates what can be achieved when our 
technology and know-how are combined with leading expert surgeons, such as Dr. 
Buly and Dr. Connor, and the visionary health care institution of HSS.  We're 
all united by the same goal: to advance patient care and to restore the eMotion 
of Motion."

The ProMade PoC Center offers the opportunity for enhanced collaboration 
between the design and manufacturing engineers and the surgeons to develop 
patient-specific solutions before being 3D printed in the onsite facility. It 
reduces by weeks the time to surgery and has become a resource available not 
only to HSS physicians, but to providers and hospitals throughout the U.S.

"The accessibility of the ProMade PoC Center is greatly beneficial to providers 
to meet the needs of patients with especially unique cases," said Dr. Connor. 
"Such customized solutions may provide a viable opportunity to those 
individuals who face very limited options for reconstruction and improve the 
chances for success."

Dr. Buly added, "3D printing has advantages over conventional machining 
particularly for the ease with which very complex shapes can be made. It is 
important for orthopedic implants to match the anatomical requirements of the 
individual, and I'm thrilled to have addressed my unique case in collaboration 
with ProMade engineers to develop a patient-specific component and expedite 
what was once a time-intensive, international production process." 

The center, established through a long-standing strategic relationship between 
HSS and LimaCorporate, is an FDA-regulated commercial facility located at the 
HSS main campus in New York City.  The aim of this innovative, first of its 
kind project is to provide faster and more accessible care for U.S. patients 
requiring personalized and unique complex joint replacement solutions.

"We couldn't be more excited to see our vision for the ProMade PoC Center 
realized with these first patient-specific implants," said Louis A. Shapiro, 
President and CEO of HSS. "HSS has always been focused on advancing the field 
of orthopedics, and we're proud to offer solutions that benefit providers and 
patients across the country. This center and our ongoing partnership with 
LimaCorporate represent HSS' innovative spirit. By sharing our knowledge and 
creating new levels of access to custom 3D printing capabilities, we hope to 
continue to empower best-in-class patient care and accelerate the development 
of new complex musculoskeletal solutions."

About LimaCorporate 

LimaCorporate is a global orthopedic company, focused on digital innovation and 
tailored hardware, which advances patient centred care.  Its pioneering 
technological solutions are developed to empower surgeons, and to improve 
patient outcomes from joint replacement surgery.  Its primary focus is on 
providing reconstructive and custom-made orthopedic solutions to surgeons, 
enabling them to improve the quality of life of patients by restoring the joy 
of movement.

Headquartered in Italy, the company operates in over 20 countries around the 
world. LimaCorporate offers products ranging from large joint revision and 
primary implants, to complete extremities solutions, including fixation.

For additional information on the Company, please visit www.limacorporate.com 
Limacorporate spa
Via Nazionale, 52
33038 Villanova di San Daniele 
Udine – Italy
t: +39 0432 945511
e.: info@limacorporate.com
w: press@limacorporate.com  


About HSS 

HSS is the world's leading academic medical center focused on musculoskeletal 
health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in 
orthopedics (for the 12th consecutive year), No. 4 in rheumatology by U.S. News 
& World Report (2021-2022), and the best pediatric orthopedic hospital in NY, 
NJ and CT by U.S. News & World Report "Best Children's Hospitals" list 
(2021-2022). In a survey of medical professionals in more than 20 countries by 
Newsweek, HSS is ranked world #1 in orthopedics for a second consecutive year 
(2021). Founded in 1863, the Hospital has the lowest complication and 
readmission rates in the nation for orthopedics, and among the lowest infection 
rates. HSS was the first in New York State to receive Magnet Recognition for 
Excellence in Nursing Service from the American Nurses Credentialing Center 
five consecutive times. An affiliate of Weill Cornell Medical College, HSS has 
a main campus in New York City and facilities in New Jersey, Connecticut and in 
the Long Island and Westchester County regions of New York State, as well as in 
Florida. In addition to patient care, HSS leads the field in research, 
innovation and education. The HSS Research Institute comprises 20 laboratories 
and 300 staff members focused on leading the advancement of musculoskeletal 
health through prevention of degeneration, tissue repair and tissue 
regeneration. The HSS Innovation Institute works to realize the potential of 
new drugs, therapeutics and devices. The HSS Education Institute is a trusted 
leader in advancing musculoskeletal knowledge and research for physicians, 
nurses, allied health professionals, academic trainees, and consumers in more 
than 145 countries. The institution is collaborating with medical centers and 
other organizations to advance the quality and value of musculoskeletal care 
and to make world-class HSS care more widely accessible nationally and 
internationally. www.hss.edu. 

Logo - https://mma.prnewswire.com/media/997351/LimaCorporate_Logo.jpg 

SOURCE: Limacorporate S.p.A.
Translations

Japanese